What is the STOP‑Bang questionnaire, how is it scored, and what are the recommended next steps based on the score for obstructive sleep apnea screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

STOP-BANG Questionnaire for OSA Screening

The STOP-BANG questionnaire is a validated 8-item screening tool for obstructive sleep apnea that should be used to stratify OSA risk, but it cannot diagnose OSA and must be followed by objective sleep testing (polysomnography or home sleep apnea testing) for definitive diagnosis. 1, 2

What is STOP-BANG?

The STOP-BANG questionnaire consists of 8 yes/no items 3:

STOP (Symptoms):

  • Snoring - Do you snore loudly?
  • Tiredness - Do you often feel tired or sleepy during the day?
  • Observed apnea - Has anyone witnessed you stop breathing during sleep?
  • Pressure - Do you have or are you being treated for high blood pressure?

BANG (Clinical attributes):

  • BMI > 35 kg/m²
  • Age > 50 years
  • Neck circumference > 40 cm (16 inches)
  • Gender - Male

Scoring and Risk Stratification

Total score ranges from 0-8 points (one point per yes answer) 3:

Standard Interpretation:

  • Score 0-2: Low risk for moderate-to-severe OSA
  • Score 3-4: Intermediate risk - requires additional criteria (see below)
  • Score 5-8: High risk for moderate-to-severe OSA 3, 4

Enhanced Stratification for Intermediate Scores (3-4):

Patients with scores of 3-4 are classified as HIGH RISK if they meet ANY of these combinations 4:

  • STOP score ≥2 AND BMI >35 kg/m²
  • STOP score ≥2 AND male gender
  • STOP score ≥2 AND neck circumference >40 cm
  • STOP-BANG ≥3 AND serum bicarbonate ≥28 mmol/L

Performance Characteristics

The STOP-BANG demonstrates high sensitivity but low specificity 2:

For moderate-to-severe OSA (AHI ≥15):

  • Sensitivity: 93% (95% CI: 0.90-0.95)
  • Specificity: 36% (95% CI: 0.29-0.44)
  • Negative predictive value: 90%

For severe OSA (AHI ≥30):

  • Sensitivity: 100%
  • Negative predictive value: 100%

As scores increase from 0-2 to 7-8 3:

  • Probability of moderate-to-severe OSA increases from 18% to 60%
  • Probability of severe OSA increases from 4% to 38%

Critical Limitation

The STOP-BANG questionnaire CANNOT be used alone to diagnose OSA - this is a STRONG recommendation from the American Academy of Sleep Medicine 2. The high false-positive rate (low specificity) means many patients without significant OSA will screen positive, while the excellent negative predictive value means a low score effectively rules out moderate-to-severe disease.

Recommended Next Steps Based on Score

Score 0-2 (Low Risk):

  • No immediate sleep study required for asymptomatic patients
  • Consider other causes if symptoms present
  • Reassess if weight gain, new cardiovascular disease, or worsening symptoms develop

Score 3-4 (Intermediate Risk):

  • Apply enhanced stratification criteria (see above)
  • If meets high-risk criteria → proceed to sleep testing
  • If remains intermediate → clinical judgment based on symptoms, comorbidities (cardiovascular disease, diabetes, hypertension), and occupational risk (commercial drivers)

Score 5-8 (High Risk):

  • Refer for comprehensive sleep evaluation by board-certified sleep medicine physician 1, 5
  • Perform objective sleep testing:
    • Polysomnography (PSG) is preferred for: patients with significant cardiorespiratory disease, neuromuscular conditions, chronic opioid use, stroke history, severe insomnia, or when comprehensive evaluation needed 2
    • Home sleep apnea testing (HSAT) acceptable for: uncomplicated patients with high pretest probability of moderate-to-severe OSA 1, 2
    • If HSAT is negative, inconclusive, or technically inadequate → must perform PSG 2

Special Populations

For patients with BMI <35 kg/m², consider using modified cut-offs 6:

  • Age ≥40 years (instead of >50)
  • Neck circumference ≥35 cm (instead of >40 cm)
  • BMI ≥23 kg/m² (instead of >35)

This modification improves sensitivity to 93-97.6% across OSA severity levels in non-obese populations.

For commercial motor vehicle operators, the VA/DOD guidelines specifically recommend the STOP questionnaire (4-item version without BANG) for initial risk stratification 1, though STOP-BANG remains widely used in transportation medicine 5.

Common Pitfalls

  1. Using STOP-BANG alone to diagnose OSA - this violates AASM strong recommendations and will result in overdiagnosis 2
  2. Ignoring intermediate scores (3-4) - these require enhanced stratification, not automatic referral
  3. Failing to perform PSG after negative HSAT - negative home studies must be confirmed with in-laboratory testing when clinical suspicion remains high 2
  4. Applying standard cut-offs to non-obese Asian populations - consider modified thresholds 6

References

2
Guideline

clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

5
Guideline

management of obstructive sleep apnea in commercial motor vehicle operators: recommendations of the aasm sleep and transportation safety awareness task force.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2017

Related Questions

What does a STOP-BANG score of 4 indicate and what management is recommended?
Should a 28-year-old male with a STOP-BANG score of 4, an Epworth Sleepiness Scale score of 8, and a BMI of 31 be referred for a sleep study?
Are there any studies demonstrating that cosmetic neck liposuction for fat reduction can improve obstructive sleep apnea?
In a 12‑month‑old male (current weight 19 lb, birth weight 7 lb) with a history of obstructive sleep apnea that has improved after specialist follow‑up and who is meeting developmental milestones, what additional recommendations should be given now besides the scheduled 15‑month well‑child visit?
How should a 7‑week‑old female born at 34 weeks gestation with recent NICU admission for apnea, presenting with cough, shortness of breath and apnea spells, be evaluated and managed?
A patient underwent a partial thyroidectomy; which ICD-10-PCS code should be used?
What is the appropriate treatment for a patient with restrictive lung disease on pulmonary function tests who is experiencing shortness of breath?
How effective are beta‑blockers for hormonal (e.g., thyroid‑induced) heart palpitations in an adult without asthma, peripheral vascular disease, bradycardia, or heart block?
Is there a lab test for serum lithium level and which ICD‑10 code should I use for therapeutic drug level monitoring?
What are the distinguishing clinical features and recommended first-line management for fibromyalgia compared with polymyalgia rheumatica?
What are the common intravenous agents used to support blood pressure in adult intensive care unit patients?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.